Marion Menozzi-Arnaud

Estimating the future global dose demand for measles–rubella microarray patches

T. Cherian, M. Meltzer, D. Durrheim, 2022, Frontiers in Public Health.

Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities

Jean‐Pierre Amorij, B. Giersing, C. Jarrahian, 2023, Expert opinion on drug delivery.

Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges

D. Durrheim, N. Crowcroft, P. Gilbert, 2022, Frontiers in Public Health.

How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making

R. Hutubessy, Ibrahima Diarra, Anna-Léa Kahn, 2020, Vaccine: X.

Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countries

Jean‐Pierre Amorij, Anna-Léa Kahn, B. Giersing, 2021, Vaccine.

Vaccine innovation prioritisation strategy: Findings from three country-stakeholder consultations on vaccine product innovations

Anna-Léa Kahn, Mercy Mvundura, B. Giersing, 2021, Vaccine.